All In Biotech

Drug Trial Radar · NCT05730699

Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)

An Open-Label Study of the Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders

Last checked: Nov 19, 2026Latest source record: Nov 7, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

105

Planned (sponsor's estimate)

Start

Dec 12, 2022

Primary completion

Jan 2025

Study completion Sep 2026

Sponsor

Lead sponsor
BiocadIndustry
Sponsor type
Industry
First posted
Feb 16, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to study the efficacy and safety of BCD-132 (divozilimab) in subjects with neuromyelitis optica spectrum disorders (NMOSD).

Conditions

  • Neuromyelitis Optica Spectrum Disorders

Interventions

  • divozilimabBiological

    anti-CD20 monoclonal antibody

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adjudicated annualized relapse rate [Week 24]Time frame: Week 24

Locations

19 sites in 1 country. Site status is shown where the registry gives one.

  • Llc "Profimed"

    Barnaul, Russia

  • Municipal Autonomous Healthcare Institution of the Order of the Red Banner of Labor "City Clinical Hospital No.1"

    Chelyabinsk, Russia

  • Regional Clinical Hospital No.3

    Chelyabinsk, Russia

  • Kuzbass Clinical Hospital named after S.V. Belyaev

    Kemerovo, Russia

  • Khanty-Mansiysk autonomous district - Ugra "The district clinical hospital"

    Khanty-Mansiysk, Russia

  • Center for Cardiology and Neurology

    Kirov, Russia

  • Regional Clinical Hospital № 1 named after Professor S. V. Ochapovsky

    Krasnodar, Russia

  • Moscow Regional Clinical Research Institute named after M.F. Vladimirsky (MONIKI)

    Moscow, Russia

  • LLC "Medis"

    Nizhny Novgorod, Russia

  • Semashko Regional Clinical Hospital

    Nizhny Novgorod, Russia

  • State Novosibirsk Regional Clinical Hospital

    Novosibirsk, Russia

  • Pyatigorsk City Clinical Hospital No.2

    Pyatigorsk, Russia

  • Federal State Budgetary Educational Institution of Higher Education "Rostov State Medical University"

    Rostov-on-Don, Russia

  • Pavlov First Saint Petersburg State Medical University

    Saint Petersburg, Russia

  • Seredavin Regional Clinical Hospital

    Samara, Russia

  • Republican Clinical Hospital No.4

    Saransk, Russia

  • Siberian State Medical University

    Tomsk, Russia

  • Medical and Sanitary Unit "Neftyanik"

    Tyumen, Russia

  • Ulyanovsk Regional Clinical Hospital

    Ulyanovsk, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.